OC3PR – Evidence-based therapies for COVID-19
About this Event
Join us at the next OC3PR webinar when we will discuss evidence-based therapies for COVID-19 and what is on the horizon for pharmacotherapy.
Dr. Bram Rochwerg
Intensivist and Researcher at McMaster University in Hamilton, Ontario
Executive for the Canadian Critical Care Society, the Internal Medicine Section at the Society of Critical Care Medicine and The Canadian Critical Care Trials Group.
At the end of this session, the participants will understand:
1. What evidence-based therapies work and when to use them (excluding anti-coagulation)
2. What probably doesn’t work or should only be used in the context of a clinical trial
3. How these decisions are made – and where to get reliable guidance
4. What is on the horizon from a pharmacotherapy standpoint specifically Tocilizimab and the IL-6 inhibitors
We invite all multidisciplinary ICU teams to participate and ask that you please share this invite with your colleagues who are involved with critical care. To further share key learning points highlighted during each webinar, we encourage teams to schedule time to debrief and discuss how the information will inform or be incorporated into practices in your hospital. The webinars will also be recorded and made available on the CCSO website along with supporting documentation.
If you have any questions that you would like to submit ahead of the webinar please send these to email@example.com with the subject line “OC3PR”.
We look forward to you joining us.
Learn more about the Ontario Critical Care Clinical Practice Rounds (OC3PR) and all other upcoming dates and topics.
April 15, 2021